Apixaban was able to restore the altered balance of endothelial nitric oxide synthase (eNOS) activity in this model of endothelial dysfunction, thereby restoring oxidative balance, indicating a potential protective effect on the endothelium [143]. The gene discussed is NOS3; the disease is endothelial dysfunction.